ライフサイエンスコーパス: scarification

1 virulent HSV-1 strain McKrae without corneal scarification.

2 se characterized by progressive interstitial scarification.

3 arvesting autologous flaps and postoperative scarification.

4 re inoculated with S aureus 2 days before VV scarification.

5 ough disrupted epidermis in a process called scarification.

6 sions, and higher skin virus levels after VV scarification.

7 ved dendritic cells in the dermis after VACV scarification.

8 FU) of adenovirus type 5 (Ad5) after corneal scarification.

9 oculated in both eyes with Ad5 after corneal scarification.

10 PF), results from aberrant wound healing and scarification.

11 noculated with Fusarium solani after corneal scarification.

12 munocompromised mice by the route of corneal scarification.

13 of Candida albicans after unilateral corneal scarification.

14 positive control) were killed 2 hours after scarification.

15 train (McKrae) that does not require corneal scarification.

16 both eyes with HSV-1 McKrae after epithelial scarification.

17 he licensed vaccinia vaccine administered by scarification.

18 an avirulent HSV-1 strain (RE) after corneal scarification.

19 Topical application without concurrent scarification also resulted in transgene delivery to 20%

20 ACAM2000 and Dryvax are administered by skin scarification and can cause progressive vaccinia, with s

21 Scarification and intradermal vaccine recipients who dev

22 n-1 double-KO mice were infected via corneal scarification and monitored for clinical signs of infect

23 unilateral laser-induced trabecular meshwork scarification and ocular hypertension, were observed wit

24 Infection required corneal scarification and replication-competent virus, and the s

25 Uninoculated mice that underwent corneal scarification (apoptosis positive control) were killed 2

26 r associations with incarceration, religious scarification, being stuck or cut with a bloody object,

27 ity of a standard smallpox vaccine, given by scarification (by bifurcated needle), to induce primary

28 irulent strains of HSV-1, even after corneal scarification, had lower virus titers in the eye, had le

29 ermal inoculation of vaccinia virus (VV), or scarification, has been used effectively for the inducti

30 Topical delivery after corneal scarification in both mouse and rat resulted in lacZ exp

31 5x10(5) plaque-forming units) by 15 puncture scarification in double-blind fashion.

32 What was unappreciated was the role that scarification itself plays in generating protective immu

33 Scarification of individuals with atopic skin disease or

34 OP was induced in 11 rhesus monkeys by laser scarification of the trabecular meshwork.

35 of SKH1 mice (Crl:SKH1-Hrhr) with MmuPV1 by scarification on their tail resulted in three clinical o

36 avirulent HSV-1 strain RE following corneal scarification or (ii) the virulent HSV-1 strain McKrae w

37 Mice were immunized with rVV by dermal scarification or i.p. injection to determine the contrib

38 pulmonary pathology observed between dermal scarification or i.p. vaccinated mice was not reflected

39 led 'physical dormancy' often require either scarification or passage through an animal gut (replete

40 days (OR = 2.9; 95% CI: 1.3-6.6), religious scarification (OR = 2.8; 95% CI: 1.2-7.0), having been s

41 ntroduced into patients via a process called scarification, performed with a bifurcated needle contai

42 These effects of scarification presumably reflect the unique immunologica

43 n with or without virus, suggesting that the scarification process itself is a major contributor to i

44 By a wide margin, skin scarification provided the greatest protection.

45 Skin scarification (s.s.) with vaccinia virus (VACV) is essen

46 s (VACV) to superficially injured skin (skin scarification, s.s.).

47 infections and indicate that the process of scarification should be critically considered during the

48 e, utilized mass immunization using the skin scarification (SS) route.

49 een hours after inoculation of the cornea by scarification, staining was found in the scarified epith

50 s study, we applied vaccinia virus (VACV) by scarification to IL-1R1 knockout mice (IL-1R1(-/-)) and

51 Smallpox vaccine was administered by scarification using 15 skin punctures in the deltoid reg

52 lesions developed in a higher proportion of scarification vaccinees.

53 Dryvax challenge by scarification was conducted in 36 healthy subjects who h

54 irculating, memory CD8(+) T cells primed via scarification were functionally superior and conferred e

55 ed that VACV infection and replication after scarification were limited to the epidermal layer of wil

56 duced in immunosuppressed mice after surface scarification, which resulted in infection and clinical

57 te were inoculated in each eye after corneal scarification with 1.5 x 10(6) plaque-forming units per

58 response occurs within the first 2 min after scarification with or without virus, suggesting that the

59 ganglia for LATs 1 and 8 weeks after corneal scarification with ribonucleotide reductase-deficient HS

60 Rabbits vaccinated via scarification with the three attenuated derivatives (SCH

61 Treatment at the time of tail scarification with vaccinia virus did not block vaccinat

62 Following scarification with VV, both transgenic and wild-type mic